Call for universal Hepatitis B vaccination
pharmafile | August 22, 2008 | News story | Sales and Marketing |Â Â hepatitisÂ
The pharma industry has joined up with patient groups to petition for universal Hepatitis B immunisation for all children in the UK.
The ABPI, the British Liver Trust and the Hepatitis B Foundation want the government to change its policy on the life-threatening disease and fall into line with other European countries.
"Lives are being put at risk. A programme needs to be put into place to ensure that all British children are inoculated against Hepatitis B," said the ABPI's medical director Dr Richard Tiner.
"It is a matter of public health. Much of the rest of Europe operates mass childhood vaccination programmes; it is time that the UK followed suit."
Hepatitis B is 50 times more infectious than HIV and affects more than 325,000 patients in the UK. There is no cure and chronic Hepatitis B can develop into potentially fatal conditions such as liver cancer and cirrhosis.
Related Content

FDA approves Wegovy for treatment of MASH in adults with liver fibrosis
The US Food and Drug Administration (FDA) has granted accelerated approval for Wegovy (semaglutide) as …

First patient dosed in Assembly Biosciences’ phase 1b trial for hepatitis B treatment
Assembly Biosciences has announced that the first participant has been dosed in its phase 1b …

NICE recommends Hepcludex for NHS use to treat aggressive form of viral hepatitis
The National Institute for Health and Care Excellence (NICE) has recommended Hepcludex (bulevirtide) for the …






